000 01509 a2200373 4500
005 20250515231636.0
264 0 _c20101201
008 201012s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00620-10
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBohnert, Jürgen A
245 0 0 _aOptimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cSep 2010
300 _a3770-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aCarbonyl Cyanide m-Chlorophenyl Hydrazone
_xpharmacology
650 0 4 _aChlortetracycline
_xpharmacology
650 0 4 _aDipeptides
_xpharmacology
650 0 4 _aDoxorubicin
_xpharmacology
650 0 4 _aDoxycycline
_xpharmacology
650 0 4 _aDrug Resistance, Multiple, Bacterial
650 0 4 _aEscherichia coli
_xdrug effects
650 0 4 _aEscherichia coli Proteins
_xmetabolism
650 0 4 _aMinocycline
_xpharmacology
650 0 4 _aOnium Compounds
_xpharmacology
650 0 4 _aOrganophosphorus Compounds
_xpharmacology
650 0 4 _aTetracycline
_xpharmacology
700 1 _aKaramian, Brian
700 1 _aNikaido, Hiroshi
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 54
_gno. 9
_gp. 3770-5
856 4 0 _uhttps://doi.org/10.1128/AAC.00620-10
_zAvailable from publisher's website
999 _c19952428
_d19952428